Akgul, OzgurBaycan, Omer FarukBulut, UmitSomuncu, Mustafa UmutPusuroglu, HamdiOzyilmaz, SinemGul, MehmetDemir, Ali RizaYilmaz, EmreYazan, SerkanKokturk, UgurCetin, IlyasUyarel, Huseyin2020-10-222020-10-222015-11-01Akgul O., Baycan O. F. , Bulut U., Somuncu M. U. , Pusuroglu H., Ozyilmaz S., Gul M., Demir A. R. , Yilmaz E., Yazan S., et al., -Long-term prognostic value of elevated pentraxin 3 in patients undergoing primary angioplasty for ST-elevation myocardial infarction-, CORONARY ARTERY DISEASE, cilt.26, ss.592-597, 2015http://hdl.handle.net/20.500.12645/24882Objectives The prognostic value of pentraxin 3 (PTX3) has been documented in patients with acute coronary syndrome. However, its long-term prognostic value in acute ST-segment elevation myocardial infarction (STEMI) remains unclear. The aim of this study was to evaluate the prognostic value of PTX3 in patients with STEMI undergoing a primary percutaneous coronary intervention (PCI).ArticleWOS:0003695980000098494241441310.1097/mca.000000000000028026061437